Rather a high voice for a cat.
SA - "Horizon Pharma: Upside Potential Still Significant" (5/15)
Table of revenue assumptions by product to agree with OR take exception to, Take your pick!
Flat lining around $17 with 9.8% divvy. Perhaps a good alternative who feel uncomfortable with PSEC's current situation - especially if you're holding in an IRA.